검색
Aytu Biopharma Inc
AYTU관심 목록에 추가
2.190USD
-0.080-3.52%
종가 05/15, 16:00（ET）시세는 15분 지연됩니다
23.51M시가총액
손실P/E TTM
자세한 내용은 Aytu Biopharma Inc 회사
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc 정보
종목 코드 AYTU
회사 이름Aytu Biopharma Inc
상장일Oct 20, 2017
CEODisbrow (Joshua R)
직원 수82
유형Ordinary Share
회계 연도 종료Oct 20
주소7900 E. Union Avenue
도시DENVER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호80237
전화17204376580
웹사이트https://aytubio.com/
종목 코드 AYTU
상장일Oct 20, 2017
CEODisbrow (Joshua R)
Aytu Biopharma Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
수익 분석
통화: USD마지막 업데이트: Mon, Apr 6
통화: USD마지막 업데이트: Mon, Apr 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
주식 보유 통계
마지막 업데이트: Sun, May 10
마지막 업데이트: Sun, May 10
주주
주주 유형
주주
주주
비율
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
7.58%
AWM Investment Company, Inc.
5.77%
Lytton (Laurence W)
4.99%
Diadema Partners LP
2.85%
기타
68.68%
주주
주주
비율
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
7.58%
AWM Investment Company, Inc.
5.77%
Lytton (Laurence W)
4.99%
Diadema Partners LP
2.85%
기타
68.68%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
16.18%
Hedge Fund
16.10%
Individual Investor
8.98%
Investment Advisor
3.85%
Venture Capital
0.24%
기타
54.64%
기관 주식 보유
마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
69
3.87M
36.10%
-493.52K
2025Q4
61
3.62M
34.64%
--
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Nantahala Capital Management, LLC
1.09M
10.13%
--
--
Dec 31, 2025
Stonepine Capital Management, LLC
813.70K
7.58%
-78.15K
-8.76%
Dec 31, 2025
AWM Investment Company, Inc.
619.57K
5.77%
--
--
Dec 31, 2025
Lytton (Laurence W)
535.32K
4.99%
+413.25K
+338.56%
Dec 31, 2025
Diadema Partners LP
305.79K
2.85%
+33.12K
+12.15%
Dec 31, 2025
Disbrow (Joshua R.)
207.20K
1.93%
+53.95K
+35.20%
Oct 13, 2025
Two Sigma Investments, LP
149.63K
1.39%
+41.10K
+37.86%
Dec 31, 2025
Persistent Asset Partners Limited
79.42K
0.74%
+16.96K
+27.16%
Dec 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
비율0%
DFA Dimensional US Sustainability Core 1 ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
날짜
배당락일
유형
비율
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
